Thyroid hormone receptor mutations in cancer
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 213 (1) , 23-30
- https://doi.org/10.1016/j.mce.2003.10.051
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populationsActa Endocrinologica, 2003
- Somatic Mutation of TR Can Cause a Defect in Negative Regulation of TSH in a TSH-Secreting Pituitary TumorJournal of Clinical Endocrinology & Metabolism, 2001
- Aberrant Alternative Splicing of Thyroid Hormone Receptor in a TSH-Secreting Pituitary Tumor Is A Mechanism for Hormone ResistanceMolecular Endocrinology, 2001
- Analyses ofMYC,ERBB2, andCCND1Genes in Benign and Malignant Thyroid Follicular Cell Tumors by Real-Time Polymerase Chain ReactionThyroid®, 2001
- Thyroid Hormone Receptor Is a Negative Regulator in p53-Mediated Signaling PathwaysDNA and Cell Biology, 1998
- Tumor Suppressor p53 Is a Negative Regulator in Thyroid Hormone Receptor Signaling PathwaysJournal of Biological Chemistry, 1997
- Genetic and Clinical Features of 42 Kindreds with Resistance to Thyroid Hormone: The National Institutes of Health Prospective StudyAnnals of Internal Medicine, 1995
- Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA.The EMBO Journal, 1994
- Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissueJournal of Clinical Endocrinology & Metabolism, 1994
- The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.Molecular and Cellular Biology, 1993